Home » Roche: Europe Approves Drug for Advanced Leukaemia
Roche: Europe Approves Drug for Advanced Leukaemia
The European Commission has approved Roche Holding AG’s MabThera cancer drug to treat patients whose chronic lymphocytic leukaemia returns, the Swiss drugmaker said.
Forbes
Forbes
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May